Page 1

Summary of Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31 , 2022 October 29 , 2021 These financial statements have been prepared for reference only in accordance with accounting principles and practices generally accepted in Japan . MEDIPAL HOLDINGS CORPORATION Code number : 7459 Representative : Shuichi Watanabe , President and CEO Stock exchange listing : Tokyo https://www.medipal.co.jp Phone : + 81-3-3517-5171 Contact : Yuji Sakon , Director and General Manager of Administration Division Filing of Quarterly Report ( scheduled ) : November 11 , 2021 Start of Distribution of Dividends ( scheduled ) : December 2 , 2021 Preparation of Supplementary Materials for the Quarterly Financial Results : Yes Presentation Meeting for Quarterly Financial Results : Yes ( For institutional investors and analysts ) ( All amounts are rounded down to the nearest million yen . ) 1. Consolidated Results for the Interim Period of the Fiscal Year Ending March 31 , 2022 ( April 1 , 2021 to September 30 , 2021 ) ( 1 ) Sales and Income ( Percentages represent change compared with the corresponding period of the previous fiscal year . ) Net sales ( \ million ) Year - on - year change ( % ) Operating profit ( ¥ million ) Year - on - year change ( % ) 1,643,244 1,588,418 ( 4.0 ) 24,278 18,002 ( 35.6 ) Ordinary profit ( ¥ million ) 33,558 23,987 Year - on - year change ( % ) ( 31.0 ) Six months ended September 30 , 2021 Six months ended September 30 , 2020 Note : Comprehensive income : Six months ended September 30 , 2021 : ¥ 24,295 million ( — % ) ; Six months ended September 30 , 2020 : ¥ 31,109 million ( + 60.0 % ) Six months ended September 30 , 2021 Six months ended September 30 , 2020 Profit attributable to owners of parent ( ¥ million ) 18,525 11,928 Year - on - year change ( % ) Earnings per share ( ¥ ) Earnings per share ( diluted ) ( ¥ ) ( 28.0 ) 88.23 56.81 82.79 53.24 Note : MEDIPAL HOLDINGS CORPORATION has applied the Accounting Standard for Revenue Recognition ( ASBJ Statement No. 29 ) effective from the beginning of the first quarter of the fiscal year ending March 31 , 2022. Therefore , year - of - year changes are not shown for the interim period of the fiscal year ending March 31 , 2022. For results before the application of this accounting standard , see “ 1. Qualitative Information on Quarterly Financial Results ( 1 ) Description of Results of Operations " on page 2 of the attached materials . ( 2 ) Financial Position Total assets ( \ million ) Net assets ( ¥ million ) Net worth ratio ( % ) Net assets per share ( ¥ ) As of September 30 , 2021 As of March 31 , 2021 31.1 ( Reference ) Net worth : As of September 30 , 2021 : ¥ 537,571 million ; As of March 31 , 2021 : ¥ 523,014 million 1,724,150 1,679,934 657,219 638,933 31.2 2,560.32 2,490.98 ( 3 ) Cash Flows Six months ended September 30 , 2021 Six months ended September 30 , 2020 2. Cash Dividends Cash flows from operating activities ( \ million ) 24,735 14,059 Cash flows from investing activities ( \ million ) ( 18,732 ) ( 4,073 ) Cash flows from financing activities ( \ million ) ( 6,471 ) ( 8,513 ) Cash and cash equivalents at end of period ( million ) 239,578 226,013 Year ended March 31 , 2021 Year ending March 31 , 2022 1st Quarter 2nd Quarter 21.00 21.00 Dividends per share ( ¥ ) 3rd Quarter Year - end 21.00 Full year 42.00 21.00 42.00 Year ending March 31 , 2022 ( est . ) Note : There are no revisions to the dividend forecast announced on May 13 , 2021 .